The Home Infusion Data Deficit & Patient Safety @HomeCare Magazine
March 19, 2019
Catch the latest article by Shaul Eitan @HomeCare Magazine
Shaul Eitan is the CEO of Avoset Health and previously served as COO of QCore Medical
Device upgrades the industry needs to improve patient outcomes
by Shaul Eitan March 1, 2019
Home infusion is playing a growing role in the health care industry. Every day, approximately 60,000 people undergo infusion treatments from the comfort of their homes. Home and alternate-site infusion is an $11 billion industry and is projected to reach $28.3 billion by 2024. Further driving the trend toward home treatment are new Medicare coverage options making therapy more accessible for patients.
Despite the industry’s footprint, it lacks reliable, large-scale data to accurately refine its devices and drug delivery methods. Studies exploring this aspect of medical care rely on patient self-reporting for a measure as basic and critical as patient adherence. The lack of data needs to be addressed before home infusion can expand to a wider range of patients.